Page 41 - Siam Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Phuket private sector makes plea to buy own vaccines Phuket private sector makes plea to buy own vaccines PHUKET: Leading figures from Phuket’s tourism and other industries have made a united plea for the national government to allow private businesses and even local municipalities on the island to buy their own vaccine doses to ensure that Phuket will be allowed to re-open to receive international tourists under the ‘Phuket Sandbox’ model on July 1. Thursday 29 April 2021, 06:06PM Leading Phuket business figures Sarayuth Mallam (left) and Bhummikitti Ruktaengam, President of the Phuket...

Local AstraZeneca jab ready by June 127 Citing progress, FDA OKs Siam Bioscience published : 29 Apr 2021 at 04:00 127 AstraZeneca's plan to produce its Covid-19 vaccine in Thailand has made significant progress and the first batch of vaccines will be ready for delivery to the government by June. The Food and Drug Administration (FDA) has approved Siam Bioscience as a manufacturing facility for AstraZeneca's Covid-19 vaccine. The company, together with Siam Bioscience, has been working tirelessly to ensure that the facility is on track to safely deliver supply to s...

Local AstraZeneca vaccine ‘fit for use’ Local AstraZeneca vaccine ‘fit for use’ THAILAND: Samples of the AstraZeneca vaccine licensed to be produced locally by Siam Bioscience have passed the standard set by the Department of Medical Sciences (DMS), according to the department. Photo: AFP. DMS director-general Dr Supakit Sirilak said yesterday (Apr 27) that samples of five models of the vaccine, which had been tested for consistency in production, were presented to the department for approval. The vaccine, which has been registered with the Food and Drug Administration (FDA), was manu...

Samples of AstraZeneca vaccine licensed to be produced locally by Siam Bioscience have passed the standard set by the Department of Medical Sciences (DMS), according to the department.

Local AZ vaccine 'fit for use' published : 28 Apr 2021 at 09:07 Samples of AstraZeneca vaccine licensed to be produced locally by Siam Bioscience have passed the standard set by the Department of Medical Sciences (DMS). The vaccine passed the full tests for requirements. The results of the analysis of the vaccine's quality will support having the vaccine mass-produced by Siam Bioscience, according to the DMS. Last Friday, the FDA gave Siam Bioscience approval to increase its production capacity. The company is expected to deliver the first batch of loca...